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I.  INTRODUCTION
           MR spectroscopy is a sequence in Magnetic Resonance Imaging which provides a 
measure of brain chemistry, a means of non invasive imaging that measures relative 
levels of various tissue metabolites. 1
MRS, in the 1970s, involved phosphorus 31P spectroscopy in animals, including 
evaluation  of  red  blood cells  and  rat  leg  muscle  tissue.  Human application  became 
possible in 1980s, when large bore magnets became available. The first human brain 
applications involved  31P spectroscopy in infants.  Bottmley and Radda and other co-
authors  then  described  applications  of  in  vivo  31P spectroscopy  in  the  adult  brain, 
followed in 1985 by the earliest in vivo brain hydrogen 1H spectroscopic studies. 2
The most  common nuclei  that  are used are  1H (proton),  23Na (sodium),  &  31P 
(phosphorus). Proton spectroscopy is easier to perform and provides much higher signal-
to-noise than either sodium or phosphorus. Proton MRS can be performed within 10-15 
minutes and can be added on to conventional MR imaging protocols. It can be used to 
serially monitor biochemical changes in tumors, stroke, epilepsy, metabolic disorders, 
infections, and neurodegenerative diseases. Magnetic  resonance  spectroscopy  allows 
noninvasive and in vivo exploration of the molecular composition of tissue. It identifies 
certain  molecular  constituents  -  the  metabolites  -  involved  in  physiological  or 
pathological processes.
The important metabolites evaluated in long TE proton MR spectra are,             
 N-Acetyl aspartate
 Choline 
 Creatinine / phosphocreatinine
 Lactate 
The important metabolites evaluated in short TE proton spectra (in addition to the above 
metabolites) are,
 Glutamate 
 Glutamine 
 Gamma-amino butyric acid
 Myo-Inositol
 Alanine
 Glucose
 Lipid 3
The following picture shows proton spectra in the normal adult brain tissue in single 
voxel.              
The  above  metabolites  in  various  brain  tumors  were  studied  and  the  post  op 
histopathology was correlated in this study.
II. AIM OF THE STUDY
To analyze the MR spectroscopy of the space occupying lesions in the brain with 
the post operative histopathology and try to find the reliability of MRS in making a 
pathological diagnosis pre operatively.
To analyze the spectroscopic diagnosis in association with parent images like CT 
brain (Plain & contrast) and conventional MRI (T1W,T2W & DWI) before giving the 
final imaging diagnosis.
To compare the results of our study with works available in the literature.
III.   MATERIAL AND METHODS
This  was  a  prospective  study  conducted  in  the  department  of  Neurosurgery, 
Stanley Medical College, Chennai, during Feb 2005 – Dec 2008.
The 35 patients who presented with intracranial lesions diagnosed with CT Brain 
were done MRI & MR spectroscopy, where MRS pathological probable diagnosis was 
correlated with postoperative actual histopathological diagnosis of the lesion. For all the 
patients MRS was done using 1.5 Tesla magnets TE30 / TE136 / TE144 / TE270 using 
single voxel followed by resection of the SOL.
The space occupying lesions of more than 2 cm size was taken for the study.The 
total number of patients was 35 including 21 males, 10 females and 4 children.
            SITE OF THE SOL:
 Supratentorial lesions – 31 cases
Infra tentorial lesions - 4 cases
PROCEDURES PERFORMED:
Craniotomy and excision - 30
Suboccipital craniectomy & decompression of SOL - 4
Burr hole and tapping - 1
All patients were done suture removal on the 8th post operative day and discharged 
on 10th post operative day. 
We could arrive at a probable pathological diagnosis of the lesions using MRI 
with the following findings.
• Astrocytoma : 
Reduced NAA levels, moderately reduced Cr levels, and elevated Choline levels
Abnormally low NAA/Cr ratio & elevated Cho/Cr ratios
Elevated choline levels are seen more consistently in anaplastic astrocytomas than 
GBM.
Ependymomas display higher Cho/Cr ratios than those noted for astrocytomas in 
general.
Lactate levels may be elevated in all cysts regardless of etiology.
In highly vascular tumors lactate may be rapidly removed from the tumor and 
lactate spectra may not be present.
The presence of elevated lipid levels has also been used to differentiate low-grade 
from high-grade neoplasms, which is more specific for high grade tumor.
Lipids  may  originate  from  the  tumor  cells  with  in  high  grade  astrocytomas, 
macrophages along the tumor periphery or areas of necrosis
• Meningioma:
Elevated alanine at 1.48 ppm is a signature of meningiomas.
The  Cho/Cr  ratio  is  higher  in  malignant  meningiomas  than  in  benign 
meningiomas
No lipid/ lactate.
• Metastases :
MRS  of  metastases  is  often  nonspecific  and  indistinguishable  from  those  of 
primary brain tumors.
But  Lipid  and  lactate  peak  were  more  common  with  metastases  than 
astrocytomas.
• Radiation necrosis:
Elevated lactate levels 
No choline peak.
• Hamartomas :
NAA/Cho,  NAA/Cr  and  Cr/Cho  ratios  in  hamartomas  are  closer  to  those  of 
normal brain tissue than to those of gliomas.
• Bacterial Abscess:
Acetate, succinate & Amino acid ( alanine) peak in the cavity.
Cytosolic acid peak in the wall
Lipid peak inside the cavity
• Tuberculoma:
Prominent lipid resonances 
Important peaks at the 1.3 and 0.9 ppm, corresponding to the methyl groups of 
fatty acid.
• Lymphoma:
Choline peak
Lipid lactate peak
• Schwannoma:
Absence of creatine, marked reduction in NAA, and increased lipids
• Infarct :
Decrease in NAA level, and lactate peak
• Epidermoid:
Lipid peak
The operated specimens were sent for Histopathological examination.
IV.  RESULTS
The  operated  specimens  were  sent  for  Histopathological  examination  and  the 
reports were compared with the pre operative MR Spectroscopical Data.
The  following  table  showing  the  list  of  patients  with  MRS  diagnosis  and 
Histopathological Diagnosis
Total number of patients 35.
CASE
NO MRS DIAGNOSIS
HISTOPATHOLOGICAL 
DIAGNOSIS
1 LOW GRADE GLIOMA GRADE 2 GLIOMA
2 ABSCESS ABSCESS
3 GLIOMA GRADE 3 GLIOMA
4 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
5 LOW GRADE GLIOMA GRADE 1 GLIOMA
6 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
7 HIGH GRADE GLIOMA LOW GRADE GLIOMA
8 LYMPHOMA LYMPHOMA
9 INCONCLUSIVE GANGLIOGLIOMA
10 LOW GRADE GLIOMA PILOCYTIC ASTROCYTOMA
11 LOW GRADE GLIOMA GRADE 2 GLIOMA
12 CRANIOPHARYNGIOMA Grade 2 GLIOMA
13 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
14 GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOMA 
MULTIFORME
15 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
CASE
NO MRS DIAGNOSIS
HISTOPATHOLOGICAL 
DIAGNOSIS
16 HIGH GRADE GLIOMA GRADE 3 GLIOMA
17 CEREBELLAR ABSCESS CHRONIC ABSCESS
18 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
19 HIGH GRADE GLIOMA GRADE 3 GLIOMA
20 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
21 INCONCLUSIVE MENINGOTHELIAL 
MENINGIOMA
22 GLIOMA TUBERCULOMA
23 HIGH GRADE GLIOMA INFARCT
24 GLIOMA MENINGIOMA
25 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
26 ABSCESS MENINGIOMA
27 INCONCLUSIVE GLIOMA
28 GLIOMA MENINGIOMA
29 GLIOMA LYMPHOMA
30 LOW GRADE GLIOMA GRADE-2 GLIOMA
31 HIGH GRADE GLIOMA SECONDARIES
32 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
33 EPIDERMOID EPIDERMOID
34 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
35 ABSCESS ABSCESS
The post op histopathology turned out to be Glioma in 22 patients , Meningioma 
in  4 patients, Abscess in 3,Lymphoma in 2,  Tuberculoma in 1 patient, Epidermoid in 1 
patient Metastatic secondaries in 1 patient ,and infarct in 1 patient.
The pre operative probable MRS pathological diagnosis was correlated with the 
post operative histopathology in 24 cases. 
THE  FOLLOWING  TABLE  SHOWING  THE  CORRELATED  LIST  OF 
PATIENTS
CASE 
NO MRS DIAGNOSIS
HISTOPATHOLOGY 
REPORT
1 LOW GRADE GLIOMA GRADE 2 GLIOMA
2 ABSCESS ABSCESS
3 GLIOMA GRADE 3 GLIOMA
4 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
5 LOW GRADE GLIOMA GRADE 1 GLIOMA
6 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
7 HIGH GRADE GLIOMA GRADE 2 GLIOMA
8 LYMPHOMA LYMPHOMA
10 LOW GRADE GLIOMA PILOCYTIC ASTROCYTOMA
11 LOW GRADE GLIOMA GRADE 2 GLIOMA
13 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
14 GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOMA 
MULTIFORME
15 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
16 HIGH GRADE GLIOMA GRADE 3 GLIOMA
17 CEREBELLAR 
ABSCESS CHRONIC ABSCESS
18 HIGH GRADE GLIOMA GLIOBLASTOMA 
CASE 
NO MRS DIAGNOSIS
HISTOPATHOLOGY 
REPORT
MULTIFORME
19 HIGH GRADE GLIOMA GRADE 3 GLIOMA
20 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
25 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
30 LOW GRADE GLIOMA GRADE-2 GLIOMA
32 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
33 EPIDERMOID EPIDERMOID
34 HIGH GRADE GLIOMA GLIOBLASTOMA 
MULTIFORME
35 ABSCESS ABSCESS
In Gliomas , 
The  MRS  diagnosis  of  a  low  grade  Glioma  was  made  in  6  cases  and 
histopathology was also the same. 
The  MRS  diagnosis  of  high  grade  Glioma  was  made  in  13  patients  and  the 
histopathology was also the same.
In the 6 patients of low grade Glioma, the MRS diagnosis of high grade Glioma 
was made in one and the histopathology showed grade 2 Glioma.
The MRS diagnosis of abscess was made in 3 cases and the histopathology was 
also the same.
One  case  of  lymphoma,  one  tuberculoma  ,  and  one  epidermoid  were  also 
correlated with MRS diagnosis.
THE  FOLLOWING  TABLE  SHOWING  THE  NON-CORRELATED  LIST OF 
PATIENTS
CASE 
NO
MRS DIAGNOSIS HISTOPATHOLOGY REPORT
9 INCONCLUSIVE GANGLIOGLIOMA
12 CRANIOPHARYNGIOMA GLIOMA
21 INCONCLUSIVE
MENINGOTHELIAL 
MENINGIOMA
22 GLIOMA TUBERCULOMA
23 GLIOMA INFARCT
24 GLIOMA MENINGIOMA
26 ABSCESS MENINGIOMA
27 INCONCLUSIVE GLIOMA
28 GLIOMA MENINGIOMA
29 HIGH GRADE GLIOMA LYMPHOMA
31 HIGH GRADE GLIOMA SECONDARIES
In  11 patients the MRS diagnosis was different or inconclusive.
In case-no 9 , the MRS was inclusive because of the extensive calcification in the 
lesion. The CT and conventional MRI gave the diagnosis of calcified lesion probably 
ganglioglioma. The post operative histopathology turned out to be ganglioglioma.
In case no 12;   the MRS diagnosis was craniopharyngioma as the graph showed 
lipid peak and no choline peak. But the post operative histopathology turned out to be a 
glioma.
In case no 21, the MRS diagnosis was inconclusive due to calcifications. The post 
operative histopathology was meningioma.
In case no 22, the MRS diagnosis was glioma  as the graph showed choline peak 
and no lipid or lactate trace. But the post operative histopathology was tuberculoma.
In case no 23, the MRS diagnosis was glioma as the graph showed both choline 
and lipid peak. But the post operative histopathology was an infarct.
In   case  no  23,  although  the  CT ,  and  conventional  MRI  pictures  gave  the 
diagnosis  of  meningioma,  the  MRS  graph  showed  the  choline  peak  and  the  MRS 
diagnosis was Glioma. But the histopathology was meningioma.
In case no 24, the MRS diagnosis was abscess as the graph showed alanine peak. 
But the intra operative and histopathology diagnosis was meningioma.
In case no 27, as the MRS gave irregular graphs the MRS diagnosis was given as 
teratoma. The histopathology turned out to be glioma.
In case no 28, an intraventricular SOL , as it showed choline peak and no alanine 
trace, the MRS diagnosis was glioma. But the post operative histopathology was turned 
out to be meningioma.
In case no 29, a double lesion in thalamic and occipital region, MRS diagnosis 
was high grade glioma, but the histopathology turned out to be lymphoma.
In case no 31 , because the tumor showed choline and lipid peak the diagnosis of 
high grade glioma was given and the histopathology turned out to be a secondary deposit 
from carcinoma lung.
V.  ANALYSIS
In the total number of 35 patients, 24 patients correlated and 11 patients did not 
correlate with the MRS diagnosis. 
In Gliomas, 
MRS diagnosis and histopathological diagnosis were same in 19 patients. These 
patients  showed  typical  of  glioma  traces  in  MRS  including  reduced  NAA levels, 
moderately reduced Cr levels, and elevated Choline levels. High grade gliomas showed 
lipid lactate peak along with the above features.  In one patient the MRS diagnosis was 
high grade glioma as there was associated lactate peak. But the histopathology turned 
out to be low grade glioma. 
MRS diagnosis of non Glioma but histopathologically of Glioma was made in 3 
patients. In one patient with lesion in left temporal region with calcifications, the graphs 
were  distorted  and  multiple  with  no  significant  peak.  The  histopathology  was 
ganglioglioma. In another patient lesion showed lipid peak without choline peak in a 
suprasellar region. It was diagnosed as craniopharyngioma but the histopathology was 
turned out to be glioma. In one patient with pineal region cystic SOL, the MRS showed 
inconclusive  graphs.  Tumor  was  thought  to  be  teratoma but  the  histopathology  was 
glioma.
The MRS diagnosis of Glioma and histopathologically of non Glioma was present 
in 6 patients. This includes 2 meningiomas, a tuberculoma, an infarct, a lymphoma and a 
secondary deposit. All these patients showed choline peak with or without lipid peak 
without the typical MRS features of the respective histopathology. 
In meningiomas,
MRS  diagnosis  of  meningioma  was  not  made,  but  the  post  operative 
histopathology of meningioma was seen in 4 patients who were diagnosed by MRS as 
glioma in one, abscess in one and the graphs were inconclusive in 2 due to calcification.
In the 1st patient it showed choline peak, in the second one it showed alanine but at 
that time period (2006) it was indicative of an abscess and diagnosis of abscess was 
made. In the last 2 patients because of the calcification seen in meningiomas the graphs 
were  inconclusive.  When  we  correlate  the  clinical,  CT and  Conventional  MRI  the 
diagnosis of meningioma could be made.
In Lymphomas,
2 cases were proved to be lymphomas histopathologically. One patient correlated 
with MRS and the other patient’s MRS diagnosis was suggestive of high grade glioma. 
In the non corrlelated patient when we correlate with clinical,CT, and conventional MRI 
with multiplicity of the lesion the diagnosis of lymphoma could be arrived.
In Abscess,
MRS diagosis correlated well with histopathology. But in one patient the MRS 
diagnosis was abscess and histopathology was meningioma.
In  Epidermoid  MRS  correlated  well  with  histopathology.  MRS  showed  a 
prominent lipid peak.
In a Tuberculoma , MRS diagnosis of Glioma was made due to the choline peak 
which was misleading.
In a case of infarct because of the choline peak and lipid peak it was thought to be 
a glioma. 
In a secondary deposit from carcinoma lung, the MRS diagnosis was high grade 
glioma as there was choline and lactate peak. 
In  one  patient  of  proved  low  grade  glioma,  the  MRS  diagnosis  of 
craniopharyngioma was given as it showed a lipid peak with out choline peak.
When correlating the Clinical features, CT,Conventional MRI along with MRS 
the histopathological diagnosis could be arrived to a reasonable level.  
THE  FOLLOWING  TABLE  SHOWING  THE  MRS  DIAGNOSIS  ,  DIAGNOSIS 
WITH  CLINICAL FEATURES,  CT,CONVENTIONAL MRI  ALONG  WITH  MRS 
AND HISTOPATHOLOGICAL DIAGNOSIS FOR ALL 35 PATIENTS
CASE
NO
MRS 
DIAGNOSIS
DIAGNOSIS WITH 
CLINICAL 
FEATURES, 
CT,CONVENTIONA
L MRI ALONG 
WITH MRS
HISTOPA-
THOLOGY 
REPORT
1 LOW GRADE 
GLIOMA
LOW GRADE 
GLIOMA
GRADE 2 
GLIOMA
2 ABSCESS ABSCESS ABSCESS
CASE
NO
MRS 
DIAGNOSIS
DIAGNOSIS WITH 
CLINICAL 
FEATURES, 
CT,CONVENTIONA
L MRI ALONG 
WITH MRS
HISTOPA-
THOLOGY 
REPORT
3 GLIOMA GLIOMATOSIS 
CEREBRI
GRADE 3 
GLIOMA
4 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
5 LOW GRADE 
GLIOMA
LOW GRADE 
GLIOMA
GRADE 1 
GLIOMA
6 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
7 HIGH GRADE 
GLIOMA
LOW GRADE 
GLIOMA
LOW GRADE 
GLIOMA
8 LYMPHOMA LYMPHOMA LYMPHOMA
9 INCONCLUSIVE GANGLIOGLIOMA GANGLIOGLIOMA
10 LOW GRADE 
GLIOMA
LOW GRADE 
GLIOMA
PILOCYTIC 
ASTROCYTOMA
11 LOW GRADE 
GLIOMA
LOW GRADE 
GLIOMA
GRADE 2 
GLIOMA
12 CRANIOPHARY
NGIOMA
CRANIOPHARYNGIO
MA Grade 2 GLIOMA
13 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
14 GLIOBLASTOM
A MULTIFORME
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
15 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
16 HIGH GRADE 
GLIOMA GRADE 3 GLIOMA
GRADE 3 
GLIOMA
CASE
NO
MRS 
DIAGNOSIS
DIAGNOSIS WITH 
CLINICAL 
FEATURES, 
CT,CONVENTIONA
L MRI ALONG 
WITH MRS
HISTOPA-
THOLOGY 
REPORT
17 CEREBELLAR 
ABSCESS CHRONIC ABSCESS
CHRONIC 
ABSCESS
18 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
19 HIGH GRADE 
GLIOMA
HIGH GRADE 
GLIOMA
GRADE 3 
GLIOMA
20 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
21 INCONCLUSIVE MENINGIOMA MENINGIOMA
22 GLIOMA TUBERCULOMA TUBERCULOMA
23 GLIOMA HIGH GRADE 
GLIOMA INFARCT
24 GLIOMA MENINGIOMA MENINGIOMA
25 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
26 ABSCESS / 
MENINGIOMA MENINGIOMA MENINGIOMA
27 INCONCLUSIVE TERATOMA GLIOMA
28 GLIOMA MENINGIOMA MENINGIOMA
29 GLIOMA LYMPHOMA LYMPHOMA
30 LOW GRADE 
GLIOMA GRADE-2 GLIOMA
GRADE-2 
GLIOMA
31 HIGH GRADE 
GLIOMA SECONDARIES SECONDARIES
32 HIGH GRADE 
GLIOMA
HIGH GRADE 
GLIOMA
GLIOBLASTOM
A MULTIFORME
CASE
NO
MRS 
DIAGNOSIS
DIAGNOSIS WITH 
CLINICAL 
FEATURES, 
CT,CONVENTIONA
L MRI ALONG 
WITH MRS
HISTOPA-
THOLOGY 
REPORT
33 EPIDERMOID EPIDERMOID EPIDERMOID
34 HIGH GRADE 
GLIOMA
GLIOBLASTOMA 
MULTIFORME
GLIOBLASTOM
A MULTIFORME
35 ABSCESS ABSCESS ABSCESS
THE FOLLOWING TABLE INDICATES THE LIST OF PATIENTS WHERE THE 
FINAL DIAGNOSIS IMPROVED IN WHOM WHICH WERE NON CORRELATING 
BEFORE.
SL.
NO
MRS 
DIAGNOSIS
DIAGNOSIS WITH 
CLINICAL FEATURES, 
CT,CONVENTIONAL 
MRI ALONG WITH 
MRS
HISTOPA-
THOLOGY 
REPORT
9 INCONCLUSIVE GANGLIOGLIOMA GANGLIOGLIOMA
12
CRANIO 
PHARYNGIOMA
CRANIO 
PHARYNGIOMA GLIOMA
21 INCONCLUSIVE MENINGIOMA MENINGIOMA
22 GLIOMA GLIOMA TUBERCULOMA
23 GLIOMA GLIOMA INFARCT
24 GLIOMA MENINGIOMA MENINGIOMA
26
ABSCESS  / 
MENINGIOMA MENINGIOMA MENINGIOMA
27 INCONCLUSIVE TERATOMA GLIOMA
28 GLIOMA MENINGIOMA MENINGIOMA
29
HIGH  GRADE 
GLIOMA LYMPHOMA LYMPHOMA
31
HIGH  GRADE 
GLIOMA HIGHGRADE GLIOMA SECONDARIES
The  final  pre  operative  histopathological  diagnosis  could  be  made  in  all  the 
meningiomas, a ganglioglioma and in a lymphoma. But the diagnosis didn’t alter in 5 
patients even after correlating with the clinical, CT, Conventional MRI and MRS.
We could assess the respective post operative histopathological diagnosis in 24/35 
patients pre operatively  when taking the MRS alone in to account. But after correlating 
with  patient’s  clinical  features,  CT,  Conventional  MRI  and  MRS,  the  pre  operative 
histopathological diagnosis was made in 30/35. But still 5 patients were not correlating 
with the post operative Histopathology.
VI.  STATISTICS
Total number of cases -35
Post op Histopathological report :
Gliomas – 22
Meningiomas-4
Lymphomas-2
Abscess-3
Tuberculoma-1
Epidermoid 1
Secondaries -1
Infarct -1
The cases for which MRS correlated with histopathology:
Total -24
Glioma - 19
Low grade – 6
High grade -13
Abscess -3
Lymphoma – 1
Meningioma-0
Epidermoid-1
MRS AND HPE CORRELATED – 24 PATIENTS 
P VALUE – 0.028 *
Tumor wise correlation:
Gliomas:
Total Gliomas - 22
MRS Glioma &  HPE glioma -19
MRS Non-glioma & HPE glioma – 3
MRS Glioma & HPE non glioma – 6
Sensitivity – 86.4%
Specificity – 53.8%
P value – 0.011 *
Meningioma:
Total Meningiomas - 4
MRS Meningioma & HPE Meningioma -0
MRS Non-meningioma & HPE Meningioma -4
MRS Meningioma & HPE non-Meningioma -0
Statistics can not be applied as there is no true positive cases. 
Abscess:
Total abscesses – 4
MRS Abscess & HPE  Abscess -3
MRS Non Abscess & HPE abscess -0
MRS Abscess & HPE Non abscess -1
Statistics :
Sensitivity -100%
Specificity –96.9%
P value - < 0.001**
Lymphomas:
Total lymphomas – 2
MRS Lymphoma + HPE lymphoma -1
MRS Non lymphoma + HPE Lymphoma -1
MRS Lymphoma + HPE non lymphoma -0
Statistics:
Sensitivity -50%
Specificity –100%
P value - < 0.001**
Epidermoid:
Total Epidermoid – 1
MRS Epidermoid + HPE Epidermoid -1
MRS Non Epidermoid  + HPE Epidermoid  -0
MRS Epidermoid + HPE non Epidermoid -0
Sensitivity – 100%
Specificity – 100%
P value - < 0.001**
As there  are  no  true  positive  cases  the statical  value  can not  be  obtained for 
tuberculoma, secondary metastasis and infarct.
After  correlating  with  clinical  features,  CT  Brain  plain  with  contrast, 
Conventional MRI and MRS the total number of patients who correlated with the post 
operative histopathology increased. But still 5 patients were not correlating.
Only with MRS                -         24/35
P value – 0.028*
Along with clinical features, CT Brain plain with contrast, Conventional MRI 
And MRS                  -          30/35
P value - < 0.001**
* Denotes significant at 1% level
**Denotes significant at 5% level
VII.  DISCUSSION
Proton MRS can improve the diagnostic accuracy preoperatively in brain 
tumors  and  help  in  monitoring  the  response  to  surgical,  medical  and  radiation 
management. In MRS, changing the TE , changes the type of information obtained as 
well as the appearance of the frequency domain spectrum. Different TE can be used for 
obtaining MR spectra of brain tumors. In this study different  TE (30 ms, 136ms, 144 ms 
&270ms) were used. Short TE provides slightly better tumor classification, and results 
improve when both short and long TE are considered simultaneously.   Meningioma is 
the only tumor group in which long TE performed better than short TE. With a short TE 
of 30 msec, metabolites with both short and long T2 relaxation times are observed. With 
a  long  TE  of  270  msec,  only  metabolites  with  long  T2  relaxation  times  are  seen, 
producing a spectrum with primarily NAA, creatine, and choline. One other helpful TE 
is 144 msec where inverts lactate at 1.3 ppm.
2 types of MRS are available. Single voxel and multi-voxel. As a general rule, the 
single voxel, short TE technique is used to make the initial diagnosis, because the signal-
to-noise is high and all metabolites are represented. Multi-voxel, long TE techniques are 
used to further characterize different regions of a mass and to assess brain parenchyma 
around or adjacent to the mass. Multi-voxel, long TE techniques are also used to assess 
response to therapy and to search for tumor recurrence. Multi-voxel spectroscopy is best 
to  detect  infiltration  of  malignant  cells  beyond  the  enhancing  margins  of  tumors. 
Particularly  in  the  case  of  cerebral  glioma,  elevated  choline  levels  are  frequently 
detected in edematous regions of the brain outside the enhancing mass.
The important metabolites evaluated in long TE proton MR spectra are,             
 N-Acetyl aspartate
 Choline 
 Creatinine / phosphocreatinine
 Lactate 
The important metabolites evaluated in short TE proton spectra(in addition to the above 
metabolites) are,
 Glutamate 
 Glutamine 
 Gamma-amino butyric acid
 Myo-Inositol
 Alanine
 Glucose
 Lipid 
Most  proton  spectra  today  are  described  in  terms  of  metabolite  ratio,  with 
creatinine often used as the reference standard.
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Metabolites and their significance:
Sl. 
no metabolite PPM
Normal 
value
Contributions 
from
How it is 
produced Significance
Physiologically
increased
Physiological
lydecreased
Pathologically 
Increased
Pathologically 
Decreased
1 NAA 2.01 8-9 
mmol/kg
N-Acetyl  groups, 
N-Acetyl 
aspartylglutamate,
glycoproteins& 
aminoacid 
residues  in 
peptides
Synthesized  in 
the 
mitochondria 
from  aspartate 
and acetyl CoA .
Peak  Indicates 
Normal  neuronal 
activity  that  is  the 
presence  of  intact 
glioneural 
structures. 
Normal  gray 
mater – adults
Normal  gray 
mater  -  infants 
Normal  white 
mater - infants
Normal 
White  mater-
adults
Canavan’s 
disease 
Neuronal  loss- 
neurodegenerativ
e  disease,stroke, 
brain  tumors, 
epilepsy,  & 
multiple sclerosis
2 Creatine 3.03  & 
3.94
7.5mmol/kg Methyl  protons of 
creatine& 
phosphocreatine. 
Minor 
contribution- 
GABA,Lysine&Gl
utathione 
Present  in 
neurons  as  a 
buffer in cellular 
ATP-ADP 
reservoirs
Indirect indicator of 
brain  intracellular 
energy stores.
Peak  is  used  as  an 
internal  reference 
standard  for 
characterizing  other 
metabolite  signal 
intensities.
Normal  white 
mater
Normal 
cerebellum
Malignant  Brain 
tumors 
3 Choline 3.2 1.32 
mmol/kg
Trimethylammoni
um  residues  of 
free  choline 
,phosphocholine, 
phosphatidylcholi
ne  and 
glycerophosphoch
oline
Present  in  all 
processes 
resulting  in 
hypercellularity(
primary  brain 
neoplasm/gliosis
)  or  myelin 
breakdown(dem
yelinating 
disease)
Peak  reflects  cell 
membrane 
synthesis&degradati
on
Primary  brain 
neoplasms, 
demyelinating 
disease
Hypomyelinating 
disease
4 Myo-
inositol
3.56  & 
4.06
6.56 
mmol/kg
MI-
Monophosphate & 
glycine
Present  in  glial 
cells  absent  in 
neurons.  The 
role  in  osmotic 
regulation of the 
brain  has  been 
attributed to MI.
It’s glial marker Demyelinating 
disease  & 
Alzheimer’s 
disease
Hepatic 
encephalopathy
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Sl. 
no metabolite PPM
Normal 
value
Contributions 
from
How it is 
produced Significance
Physiologically
increased
Physiological
lydecreased
Pathologically 
Increased
Pathologically 
Decreased
5 Lactate Doublet 
in  1.32 
seperate
d  by 
0.2ppm 
&  also 
in 4.1
Absent  or 
<0.5 
mmol/L
Nonspecific 
indicator  of 
anaerobis 
glycolysis
Rate of washout 
of  the  lactate 
from  the  tumor 
tissue  depends 
on  the 
vascularity.
Peak  is  a 
nonspecific 
indicator  of 
anaerobic glycolysis
Brain 
neoplasms  –
rapidly 
growing  with 
vascular 
jeopardisation.
,infarcts,hypox
ia,metabolic 
disorders  or 
seizures
6 Glutamate,
Glutamine, 
and GABA
2.1  & 
2.5
Glutamate, 
glutamine  & 
GABA
Present  in 
neurons  as 
neurotransmitter
s
Increased  in 
schizophrenia 
and epilepsy
7 Alanine 1.3  & 
1.5
Alanine Increased  in 
meningiomas, 
central 
neurocytoma
8 Lipid 1.2–1.4 Free fatty acids Necrosis
9 Cytosolic 
acid
Amino acid Bacterial 
abscess
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Basic facts about the metabolites in normal brain:
• NAA is present in very low concentration in the newborn brain, 
compared to those in the adult brain, but levels rapidly increase 
during the first 2-3yrs of life.
• Pre term infants were noted to have lower brain NAA levels 
than full-term infants. 
• Myo-inositol  forms the most  prominent  peak in  the newborn 
indicating the presence of active myelination.
• NAA & Cr levels increase during the first few weeks of life, 
Cho and MI levels decrease.
• The  Cr/Cho  ratio  increases  in  gray  matter  during  the  first  2 
years of life,  whereas the ratio remains nearly constant in white 
matter.
• Lactate  peaks  are  normally  seen  in  preterm  and  small-for-
gestational-age infants.
• In the developing brain,  proton MR spectra  demonstrate  that 
different  parts  of  brain mature at  different  rates  and at  different 
times and the more metabolically mature areas demonstrate lower 
MI and higher NAA levels than those in less mature regions of the 
brain.  Specifically,  the  basal  ganglia,  perirolandic  cortex,  and 
visual  cortex  mature  before  areas  such  as  prefrontal  cortex  and 
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temporal cortex.
• Spectral  pattern stabilizes in early adulthood, and NAA level 
begins to decrease with advancing age.
Brain tumors:
MRS can be used to determine the degree of malignancy. As 
a general rule, as malignancy increases, NAA and creatine decrease, and 
choline,  lactate,  and  lipids  increase.  NAA decreases  as  tumor  growth 
displaces  or  destroys  neurons.  Highly  malignant  tumors  have  high 
metabolic  activity  and  deplete  the  energy  stores,  resulting  in  reduced 
creatine.  Hypercellular  tumors  with  rapid  growth  elevate  the  choline 
levels.  Lipids  are  found  in  necrotic  portions  of  tumors,  and  lactate 
appears  when  tumors  outgrow  their  blood  supply  and  start  utilizing 
anaerobic  glycolysis.  To  get  an  accurate  assessment  of  the  tumor 
chemistry, the spectroscopic voxel should be placed over an enhancing 
region of the tumor, avoiding areas of necrosis, hemorrhage, calcification, 
or cysts. 
The common way to analyze clinical  spectra is to look at 
metabolite ratios, namely NAA/Cr, NAA/Cho, and Cho/Cr. Normal and 
abnormal values are shown in the table. By including a known reference 
solution when acquiring the MR spectral data, absolute concentrations of 
metabolites can be calculated. But nowadays the ratios are not used as 
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there is not much of significance. When the brain becomes ischemic, it 
switches  to  anaerobic  glycolysis  and  lactate  accumulates.  Markedly 
elevated lactate is the key spectroscopic feature of cerebral hypoxia and 
ischemia. If cerebral infarction ensues, lipids increase.
As in the case of non-glial tumors, brain abscesses destroy or 
displace brain tissue, so NAA is not present. The voxel should include the 
abscess cavity to detect the breakdown products of these lesions. Lactate, 
cytosolic  acid,  alanine,  and  acetate  are  characteristic  metabolites  in 
bacterial  abscesses.  Toxoplasmosis  and  tuberculomas  show  prominent 
peaks from lactate and lipids. 
There  is  also  considerable  interest  in  using  MRS  to 
distinguish the common focal brain lesions in AIDS patients. The most 
helpful  marker is choline,  which is elevated in lymphoma, but  low or 
absent in toxoplasmosis, tuberuloma, and cryptococcoma. Toxoplasmosis 
is characterized by markedly increased lactate and lipids and depletion of 
normal  brain metabolites.  Tuberculoma and cryptococcoma are similar 
but with relatively little lactate.  
In the initial period the ratios were used and as there were 
lots  of  variation  it  is  not  used  nowadays.  Rather  the  individual 
metabolites in multivoxel provides significance results. 
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A  common  clinical  problem  is  distinguishing  tumor 
recurrence from radiation effects several months following surgery and 
radiation  therapy.  Elevated  choline  is  a  marker  for  recurrent  tumor. 
Radiation change generally exhibits low NAA, creatine, and choline on 
spectroscopy. If radiation necrosis is  present,  the spectrum may reveal 
elevated lipids and lactate.
Most non-glial tumors have little or no NAA. They also have 
very low creatine, and elevated glutamates
Finally,  MRS  can  direct  the  surgeon  to  the  most 
metabolically  active  part  of  the  tumor  for  biopsy  to  obtain  accurate 
grading of the malignancy.
Advantages :
 It can be done with the conventional MRI.
 Takes  10-15  mins  to  complete  the  imaging  which  is  non 
invasive.
Disadvantages: 
 Small lesions of less than 2cms can not be assessed. Voxel 
contamination is more.
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 Cystic lesions produce sampling error. And also the lesions 
near bone, CSF, or blood produce sampling error.
 Calcifications in the lesion could cause inappropriate peaks 
and gives inconclusive pictures.
 Theoretically, NAA is not present in the meningiomas. But 
in clinical experience it is not uncommon to detect NAA in these 
extra axial tumors. The reason for the presence of NAA in these 
tumors  may  be  contamination  of  the  voxel  by  adjacent  normal 
brain  parenchyma,  use  of  large  voxel  ,  or  inadequate  voxel 
placement.
 Although in theory NAA should not be present in metastases 
because of their lack of neural or glial components, it frequently 
is present in proton MR spectra, presumably secondary to voxel 
comtamination  with  adjacent  brain  parenchyma or  due  to  the 
presence of N-acetylated metabolites on their cell membranes.
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VIII. CONCLUSION
 When diagnostic dilemmas present themselves, MR spectroscopy 
considered in perspective with MR imaging and clinicopathologic 
features can be useful in certain situations.
 MRS study does increase specificity, and may help in improving 
our ability to predict pre operative histological diagnosis.
  MRS can help increase ability to predict grade of the Glioma. As 
the grade increases NAA and creatine decrease and choline, lipids 
and lactate increase. 
 When correlating with the clinical features, CT and Conventional 
images , the probable pathological diagnosis can be obtained up to 
85%.
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IX.  REVIEW OF THE LITERATURE
Shimizu and associates demonstrated that high grade brain tumors 
were  associated  with  higher  Cho/reference  and  lower  NAA/reference 
values in their series.3
In their series of 27 patients with biopsy confirmed brain tumors, 
Meyerand and colleagues showed that the combination of lac/water and 
choline/water  ratio  obtained  from regions  of  contrast  enhancing  brain 
tumors  permitted  differentiation  of  low  grade  astrocytomas  from 
anaplastic astrocytomas and Glioblastoma Multiforme(GBM). 3
In  a  multi  centre  study  involving  86  cases  of  glial  tumors, 
megendank  and  coauthors  showed  that  all  tumors  demonstrated 
abnormally decreased NAA/Cr and increased Cho/Cr ratios with respect 
to normal brain parenchyma.4
Butcher and colleagues have described a series of 26 intracranial 
tumors  in  which  MRS allowed  differentiation  of  infiltrative  processes 
from circumscribed lesions but did not allow differentiation of different 
types of lesions with in each category.4
Kinoshiotal  and  colleagues  suggested  that  glycine  levels  were 
markedly elevated in GBMs, high-grade astrocytomas, ependymomas and 
medulloblastomas, whereas they were low in metastatic tumors.4
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One study involving 25 patients with cerebral astrocytomas who 
received  a  combination  of  radiation  and  chemotherapy  demonstrated 
increased.4
Grand  and  co  workers,  in  their  series  of  34  cystic  intracranial 
lesions, showed that a TE of 136 msec, the detection of an aminoacid 
resonance  at  0.9  ppm in  bacterial  abscess  allows  differentiation  from 
necrotic neoplasms, which donot show this specral peak. 3
Similar studies in the recent past 
1. Noninvasive Evaluation of Malignancy of Brain Tumors with Proton 
MR Spectroscopy – AJNR Apr AJNR Am J Neuroradiol  17:737–
747, April 1996 
Water-suppressed single-voxel point resolved spectroscopy in the 
frontal white matter of 17 healthy volunteers and 25 patients with brain 
tumors yielded spectra with peaks of N-acetyl aspartate (NAA), choline-
containing compounds (Cho), creatine/phosphocreatine (Cre), and lactate. 
These  peak  intensities  were  semiquantitated  as  a  ratio  to  that  of  the 
external  reference.  The  validity  of  the  semiquantitation  was  first 
evaluated through phantom and volunteer experiments. The variation in 
measurements of the designated region in the volunteers was less than 
10%. Normal ranges of NAA/reference, Cho/reference, and Cre/reference 
were 3.596 0.68, 1.96 6 0.66, and 1.53 6 0.64 (mean 6 SD), respectively.
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In  17  gliomas,  the  Cho/reference  value  in  high-grade  gliomas  was 
significantly higher than in low-grade gliomas. Levels of NAA/ reference 
were also significantly different in low-grade and high-grade malignancy. 
In  eight  meningiomas  (four  newly  diagnosed  and  four  recurrent),  the 
level of Cho/reference was significantlyhigher in recurrent meningiomas 
than in normal white matter or in newly diagnosed meningiomas. Higher 
grades of  brain tumors in this  study were associated with higher Cho 
reference  and lower  NAA reference  values.  These results  suggest  that 
clinical proton MR spectroscopy may help predict tumor malignancy.
2. Role of in vivo proton MR Spectroscopy in the evaluation of adult 
brain lesions – Neurology India  October-december 2003
3. Comparison  between  neuroimaging  classifications  and 
histopathological  diagnoses  using  an  international  multicenter 
brain tumor magnetic resonance imaging database -  J Neurosurg 
105:6–14, 2006
The  authors  retrospectively  assessed  the  correlation  between 
neuroimaging  classifications  and  histopathologicaldiagnoses  by  using 
multicenter  database  records  from 393 patients  with brain  tumors.  An 
ontology  was  devised  to  establish  diagnostic  agreement.  Each  tumor 
category  was  compared  with  the  corresponding  histopathological 
diagnoses  by  dichotomization.  Sensitivity,  specificity,  positive  and 
negative predictive values (PPVs and NPVs, respectively),and the Wilson 
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95%  confidence  intervals  (CI)  for  each  were  calculated.  In  routine 
reporting  of  MR imaging  examinations,  tumor  types  and grades  were 
classified  with  a  high  specificity  (85.2–100%);  sensitivity  varied, 
depending on the tumor type and grade, alone or in combination. The 
recognition of broad diagnostic categories (neuroepithelial or meningeal 
lesions) was highly sensitive, whereas when both detailed type and grade 
were  considered,  sensitivity  diverged,  being  highest  in  low-grade 
meningioma  (sensitivity  100%,  95%  CI  96.2–100.0%)  and  lowest  in 
high-grade meningioma (sensitivity 0.0%, 95% CI 0.0–65.8%) and low-
grade  oligodendroglioma  (sensitivity  15%,  95%  CI  5.2–36.0%).  In 
neuroepithelial tumors, sensitivity was inversely related to the precision 
in  reporting  of  grade  and  cellular  origin;  “glioma”  was  a  frequent 
neuroimaging  classification  associated  with  higher  sensitivity  in  the 
corresponding category. The PPVs varied among categories, in general 
being greater than their prevalence in this dataset. The NPV was high in 
all categories (69.8–100%).
The  PPVs  and  NPVs  provided  in  this  study  may  be  used  as 
estimates  of  posttest  probabilities  of  diagnostic  accuracy  using  MR 
imaging.  This  study  targets  the  need  for  noninvasively  increasing 
sensitivity in categorizing most brain tumor types while retaining high 
specificity, especially in the differentiation of high- and low-grade glial 
tumor classes.
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4. Proton  magnetic  resonance  spectroscopy  and  diffusion-weighted 
imaging  in  intracranial  cystic  mass  lesions.  -Surg  Neurol. 2007;68 
Suppl 1:S25-36  
The  differential  diagnosis  of  various  intracranial  cystic  lesions  is 
sometimes difficult on the basis of CT or MRI findings. Our objective 
was to evaluate (1)H MRS and DWI in the differential diagnosis of these 
lesions  and  in  comparison  with  conventional  MRI.  METHODS:  Fifty 
patients with intracranial cystic lesions (21 pyogenic abscesses, 23 tumor 
cysts,  3 epidermoid cysts,  and 3 arachnoid cysts) were evaluated with 
conventional MRI, DWI, and in vivo (1)H MRS. Preoperative diagnosis 
of the lesions was based on the results of DWI and in vivo MRS. All DWI 
and (1)H MRS studies were performed with a clinical 1.5-T system. The 
DWI  was  performed  using  single-shot  spin-echo  echo-planar  pulse 
sequence  with  b  =  1000  s/mm(2).  The  ADC  value  was  measured. 
Diagnostic accuracy of conventional MRI, DWI, and in vivo (1)H MRS 
was  calculated  with  respect  to  a  final  diagnosis  of  brain  abscess  vs 
nonabscess cystic tumor. 
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Lactate  and cytosolic  amino acids  with/without  succinate,  acetate,  and 
alanine were observed in 18 of 21 cases of abscesses on MRS. In 3 cases 
of  epidermoid  cysts,  lactate  was  observed  and  could  be  differentiated 
from 3  cases  of  arachnoid  cysts,  which  showed only  minimal  lactate. 
Only lactate was seen in 14 of 23 patients with tumor cysts, whereas both 
lipid/lactate  and  choline  were  visible  in  9  patients  with  tumor  cysts. 
Increased  signal  was  seen  in  20  of  21  patients  with  abscesses  and  3 
patients with epidermoid cysts on DWI. Decreased signal was observed in 
22 of 23 patients with tumor cysts and 3 patients with arachnoid cyst on 
DWI.  Diagnostic  accuracy,  sensitivity,  specificity,  positive  predictive 
value,  and  negative  predictive  value  of  conventional  MRI  for  the 
differentiation  of  brain  abscess  from  nonabscess  cystic  tumor  were 
61.4%,  61.9%,  60.9%,  59.1%,  and  63.6%,  respectively,  whereas  they 
were 93.2%, 85.7%, 100%, 100%, and 88.5% with MRS; 95.5%, 95.2%, 
95.7%, 95.2%, and 95.7% with DWI; and 97.7%, 95.2%, 100%, 100%, 
and  95.8%  with  MRS  and  DWI.  Magnetic  resonance  imaging,  when 
combined with in vivo MRS and DWI, accurately predicted the diagnosis 
in 47 (94%) of 50 and 48 (96%) of 50 of the cases, respectively. Proton 
MRS  and  DWI  are  useful  as  additional  diagnostic  modalities  in 
differentiating  intracranial  cystic  lesions.  Combination  of  DWI  with 
calculated ADC values and metabolite spectrum acquired by MRS add 
more information to MRI in the differentiation of intracranial cystic mass 
lesions
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5. Correlation  of  magnetic  resonance  spectroscopic  and  growth 
characteristics  within  Grades  II  and  III  gliomas-J  Neurosurg 
106:660–666, 2007 
The accurate diagnosis of World Health Organization Grades II and 
III  gliomas is  crucial  for  the effective treatment  of  patients  with such 
lesions.  Increased  cell  density  and  mitotic  activity  are  histological 
features  that  distinguish  Grade  III  from  Grade  II  gliomas.  Because 
increased cellular proliferation and density both contribute to the in vivo 
magnetic resonance (MR) spectroscopic peak corresponding to choline-
containing compounds (Cho), the authors hypothesized that multivoxel 
MR spectroscopy might help identify the tumor regions with the most 
aggressive growth characteristics, which would be optimal locations for 
biopsy.  They  investigated  the  ability  to  use  one  or  more  MR 
spectroscopic  parameters  to  predict  the  MIB-1 cell  proliferation  index 
(PI),  the  terminal  deoxynucleotidyl  transferase–mediated  deoxyuridine 
triphosphate nick-end labeling cell death index (DI), the cell density, and 
the ratio of proliferation to cell death (PI/DI) within different regions of 
the same tumor.
Patients with presumed Grades II or III glioma underwent 3D MR 
spectroscopic imaging prior to surgery, and two or three regions within 
the tumor were targeted for biopsy retrieval based on their spectroscopic 
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features. Biopsy specimens were extracted from the tumor during image-
guided resection, and the PI, DI, and cell density were assessed in the 
specimens using immunohistochemical methods.
The  authors  found  that  the  relative  levels  of  Cho  and  N-
acetylaspartate (NAA) correlated with the cell density, PI, and PI/DI ratio 
within different regions of the same tumor and that the association held 
for  the  subpopulation  of  nonenhancing  tumors.  The  association  was 
stronger in tumors with large ranges of Cho/ NAA values, irrespective of 
the  presence  of  contrast  enhancement.  The  findings  demonstrate  the 
validity  of  using  MR  spectroscopy  to  identify  regions  of  aggressive 
growth in presumed Grade II or III gliomas that would be suitable targets 
for retrieving diagnostic biopsy specimens.
6. Increase in glutamate as a sensitive indicator of extracellular matrix 
integrity  in  peritumoral  edema:  a  3.0-tesla  proton  magnetic 
resonance spectroscopy study - J Neurosurg 106:609–613, 2007
 The authors of previous studies based on diffusion tensor imaging 
have indicated that there are two types of peritumoral edema—namely, 
edema with preserved structural integrity of the glial matrix and edema 
with compromised glial matrix. The authors of this study hypothesized 
that  functionality  of  the  glutamate  (Glu)–glutamine  shuttle,  a  vital 
neuron–glia  interaction,  may  be  differentially  affected  by  peritumoral 
edema.  They  tested  this  hypothesis  using  proton  magnetic  resonance 
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(MR) spectroscopy on a 3.0-tesla system that is capable of quantifying 
Glu without need of editing. 
Twenty-three  patients,  each with a  single  brain tumor mass  and 
peritumoral  edema  (nine  high-grade  gliomas,  eight  metastatic  brain 
tumors, and six meningiomas), and nine healthy individuals participated 
in this  study.  Single-voxel proton MR imaging targeting the region of 
peritumoral edema was performed using a 3.0-tesla system.
Glutamate levels in the peritumoral edema of nonglial tumors was 
significantly elevated (p ,  0.01) compared with edema associated with 
glial  tumors  or  normal  white  matter.  The  finding  confirmed  that 
peritumoral edema in nonglial tumors is distinct from that of glial tumors, 
as previously indicated in diffusion tensor imaging studies. The authors 
hypothesized  that  the  former  condition  represents  a  compensatory 
increase  in  activities  of  the  Glu–glutamine  shuttle  brought  about  by 
simple expansion of the extracellular space due to edema. The assessment 
of Glu concentrations in peritumoral edema using 3.0-tesla proton MR 
spectroscopy may be developed into an objective index of the structural 
integrity of the glial matrix.
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7. Comparative Evaluation of Fungal, Tubercular, and Pyogenic Brain 
Abscesses  with  Conventional  and  Diffusion  MR  Imaging  and 
Proton MR Spectroscopy - AJNR 28 , Aug 2007 
 It is difficult to differentiate the cause of brain abscesses with the 
use of CT and MR imaging. The author did a comparative evaluation of 
pyogenic, tubercular, and fungal brain abscesses by using conventional, 
diffusion-weighted  imaging  (DWI),  and  proton  MR  spectroscopy 
(PMRS) with an aim to define the unique features that may differentiate 
among the pyogenic, tubercular, and fungal brain abscesses.
They have performed a retrospective analysis on 110 patients with 
surgically  proved  brain  abscesses.  Imaging  studies  included  T2,  T1, 
postcontrast T1, DWI, and PMRS. Apparent diffusion coefficient (ADC) 
of the wall and cavity of the abscesses were quantified. The morphologic, 
physiologic,  and  metabolite  features  of  pyogenic  (n_91),  tubercular 
(n_11), and fungal (n_8) abscesses were compared.
The pyogenic abscesses had smooth (55/91) and lobulated (36/91) 
walls,  whereas  the  tubercular  abscesses  had  smooth  (4/11),  lobulated 
(6/11),  or  crenated  walls  (1/11)  with  no intracavitary  projections.  The 
fungal abscesses showed irregular walls (lobulated 4/8, crenated 4/8) with 
intracavitary projections (8/8). The wall as well as the cavity showed low 
ADC in the pyogenic and tubercular abscesses. In the fungal abscesses, 
the  wall  and  projections  showed low ADC (8/8);  however,  the  cavity 
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itself  showed  high  ADC  (8/8).  PMRS  showed  cytosolic  amino  acids 
(89/91), acetate (25/91), and succinate (18/91) in the pyogenic abscesses, 
whereas lipid/lactate (11/11) was seen in the tubercular abscesses.  The 
fungal abscesses showed lipid (4/8), lactate (7/8), amino acids (4/8), and 
multiple peaks between 3.6 and 3.8 ppm assigned to trehalose (5/8). 
Based on the morphologic,  ADC, and metabolite  information,  it 
may  be  possible  to  differentiate  among  the  pyogenic,  tubercular,  and 
fungal brain abscesses.
8. Proton  magnetic  resonance  spectroscopy  in  pituitary 
macroadenomas: preliminary results - J Neurosurg 109: 2008
The  aim  of  this  study  was  to  correlate  proton  MR  (1H-MR) 
spectroscopy  data  with  histopathological  and  surgical  findings  of 
proliferation and hemorrhage in pituitary macroadenomas. point-resolved 
spectroscopy sequence (TR 2000 msec, TE 135 msec) with 128 averages 
and chemical shift selective pulses for water suppression was used. Voxel 
dimensions were adapted to ensure that the volume of interest was fully 
located  within  the  lesion  and  to  obtain  optimal  homogeneity  of  the 
magnetic  field.  In  addition,  water-  unsuppressed spectra  (16 averages) 
were  acquired  from  the  same  volume  of  interest  for  eddy  current 
correction,  absolute  quantification  of  metabolite  signals,  and 
determination of full width at half maximum of the unsuppressed water 
peak (FWHMwater). 
54
Metabolite concentrations of choline-containing compounds (Cho) 
were computed using the LCModel program and correlated with MIB-1 
as  a  proliferative  cell  index  from  a  tissue  specimen.In  16  patients 
harboring  macroadenomas  without  hemorrhage,  there  was  a  strong 
positive linear correlation between metabolite concentrations of Cho and 
the MIB-1 proliferative cell index (R = 0.819, p < 0.001). The metabolite 
concentrations of Cho ranged from 1.8 to 5.2 mM, and the FWHMwater 
was  4.4–11.7  Hz.  Eleven  patients  had  a  hemorrhagic  adenoma  and 
showed  no  assignable  metabolite  concentration  of  Cho,  and  the 
FWHMwater was 13.4–24.4 Hz. In 10 patients the size of the lesion was 
too  small  (<  20  mm  in  2  directions)  for  the  acquisition  of  MR 
spectroscopy data. 
The  conclusion  made  was Quantitative  1H-MR  spectroscopy 
provided  important  information  on  the  proliferative  potential  and 
hemorrhaging of pituitary macroadenomas. These data may be useful for 
noninvasive  structural  monitoring  of  pituitary  macroadenomas. 
Differences  in  the  FWHMwater  could  be  explained  by  iron  ions  of 
hemosiderin, which lead to worsened homogeneity of the magnetic field.
9. Neurosurgical  implications  of  mannitol  accumulation  within  a 
meningioma and its peritumoral region demonstrated by magnetic 
resonance  spectroscopy  –A case  report-  J  Neurosurg  108:1010–
1013, 2008
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Mannitol is widely considered the hyperosmolar therapy of choice 
in routine neurosurgical practice for the reduction of intracranial pressure 
ICP).
The  authors  present  a  unique  case  of  a  patient  with  a  large 
meningioma  treated  with  mannitol,  in  which  mannitol  accumulation 
within the tumor and its surrounding parenchyma was shown using in 
vivo magnetic resonance spectroscopy (MRS). This rare appearance of 
mannitol on MRS was characterized by a wide-based peak at 3.8 ppm, 
which  remained  detectable  several  hours  after  the  last  dose.  These 
findings provide the first in vivo evidence in support of the prevailing 
theory that mannitol leakage into the peritumoral edematous region may 
contribute to rebound increases in ICP and suggest that this phenomenon 
has the potential to occur in extraaxial tumors. Judicious use of mannitol 
in the setting of elevated ICP due to tumor may be indicated to avoid 
potentially deleterious side effects caused by its accumulation.
10.  Assessment of mitochondrial impairment in traumatic brain injury 
using high-resolution proton magnetic resonance spectroscopy -  
J Neurosurg 108:42–52, 2008 
The  goal  of  this  study  was  to  demonstrate  the  post  traumatic 
neurochemical  damage  in  normal-appearing  brain  and  to  assess 
mitochondrial dysfunction by measuring N-acetylaspartate (NAA) levels 
in  patients  with  severehead  injuries,  using  proton  (1H)  magnetic 
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resonance (MR) spectroscopy. Semiquantitative analysis of NAA relative 
to creatine-containing compounds (Cr) and choline (Cho) was carried out 
from proton spectra obtained by means of chemical shift (CS) imaging 
and single-voxel (SV) methods in 25 patients with severe traumatic brain 
injuries (TBIs) (Glasgow Coma Scale scores # 8) using a 1.5-tesla MR 
unit.
Proton  MR  spectroscopy  was  also  performed  in  5  healthy 
volunteers (controls). The SV studies in patients with diffuse TBI showed 
partial reduction of NAA/Cho and NAA/Cr ratios within the first 10 days 
after injury (means 6 standard deviations 1.59 6 0.46 and 1.44 6 0.21, 
respectively, in the patients compared with 2.08 6 0.26 and 2.04 6 0.31, 
respectively,  in  the  controls;  nonsignificant  difference).  The  ratios 
gradually declined in all  patients  as time from injury increased (mean 
minimum values NAA/Cho 1.05 6 0.44 and NAA/Cr 1.05 6 0.30, p , 0.03 
and p , 0.02, respectively). This reduction was greater in patients with less 
favorable outcomes.
In patients with focal injuries, the periphery of the lesions revealed 
identical  trends  of  NAA/Cho  and  NAA/Cr  decrease.These  reductions 
correlated  with  outcome  at  6  months  (p  ,  0.01).  Assessment  with 
multivoxel  methods (CS imaging) demonstrated that,  in diffuse injury, 
NAA  levels  declined  uniformly  throughout  the  brain.  At  40  days 
postinjury, initially low NAA/Cho levels had recovered to near baseline 
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in patients who had good outcomes, whereas no recovery was evident in 
patients with poor outcomes (p, 0.01). Using 1H-MR spectroscopy, it is 
possible to detect the posttraumatic neurochemical damage of the injured 
brain when conventional neuroimaging techniques reveal no abnormality. 
Reduction  of  NAA levels  is  a  dynamic  process,  evolving  over  time, 
decreasing and remaining low throughout the involved tissue in patients 
with poor outcomes. Recovery of NAA levels in patients with favorable 
outcomes  suggests  marginal  mitochondrial  impairment  and  possible 
resynthesis from vital neurons.
11. Proton MR Spectroscopy of Pediatric Cerebellar Tumors -  AJNR 
Am J Neuroradiol 16:1821–1833, October 1995
This  study  was  done  to  investigate  the  role  of  proton  MR 
spectroscopy in pediatric cerebellar tumor diagnosis. 
Single  voxel  pulse  sequences  with  long  echo  time  (135  or  270 
milliseconds, voxel size 8 to 19 cm3), were used to obtain proton spectra 
of primary pediatric cerebellar tumors. Eleven primitive neuroectodermal 
tumors  (patient  age,  2  to  12  years;  mean,  7  years),  11  low-grade 
astrocytomas (age, 2 to 16 years; mean, 9 years), 4 ependymomas (age, 1 
to 6 years; mean, 4 years), 1 mixed glioma ependymo-astrocytoma (age, 
11 years), 1 anaplastic ependymoma (age, 7 years), 1 ganglioglioma (age, 
14 years), and 1 malignant teratoma (age, 6 days) were studied. Control 
cerebellum spectra were acquired from five patients without abnormality 
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in cerebellum (age, 2 to 15 years; mean, 8 years). The signal intensities 
from  choline-containing  compounds  (Cho),  creatine/phosphocreatine 
(Cr),  N-acetyl-aspartate (NAA), and lactate (Lac) were quantified.  The 
mean and standard deviation of metabolite ratios were calculated. 
The control spectra ratios (NAA:Cho 5 1.49 6 0.36, Cr:Cho 5 1.13 
6 0.23) were distinct from the tumor spectra (NAA:Cho 5 0.41 6 0.27 and 
Cr:Cho 5 0.37 6 0.23). Most of primitive neuroectodermal tumors had 
low NAA:Cho (0.17 6 0.09) and Cr:Cho (0.32 6 0.19). Compared with 
primitive  neuroectodermal  tumors,  low-grade  astrocytomas  and 
ependymomas had higher NAA:Cho ratio (0.63 6 0.19 and 0.39 6 0.12). 
The Cr:Cho ratio was higher for  ependymomas (0.60 6 0.20) than for 
astrocytomas (0.27 6 0.12)  and primitive neuroectodermal  tumors.  No 
NAA was found in the malignant  teratoma.  Lac:Cho ratio was 0.66 6 
0.40, 0.58 6 0.30, and 0.08 6 0.12 for astrocytoma, ependymoma, and 
primitive neuroectodermal tumor,  respectively.  Lactate  was elevated in 
the mixed glioma ependymo-astrocytoma, ganglioglioma, and teratoma. 
The NAA and lactate signals were sometimes obscured by lipids in the 
spectra.  Discriminant  analysis  was  carried  out  using  NAA:Cho  and 
Cr:Cho ratios to differentiate the three major tumor types. The sensitivity/ 
specificity  values  for  diagnosing  astrocytoma,  ependymoma,  and 
primitive neuroectodermal tumor were found to be 0.91/0.84, 0.75/0.92, 
and 0.82/0.89, respectively, based on this study.
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In  many  cases,  proton  MR  spectroscopy  can  be  used  to  help 
differentiate  cerebellarprimitive  neuroectodermal  tumor,  low-grade 
astrocytoma, and ependymoma.
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